Prodromos Koutoukoglou

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engager.

Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engager.

Journal: Immunotherapy

Published: May 04, 2026

Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future Perspectives.

Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future Perspectives.

Journal: Cancers

Published: December 22, 2025

A Five-Year Retrospective Analysis of Neoadjuvant Therapy in Early-Stage Breast Cancer: Subtype Outcomes and Imaging Concordance.

A Five-Year Retrospective Analysis of Neoadjuvant Therapy in Early-Stage Breast Cancer: Subtype Outcomes and Imaging Concordance.

Journal: The breast journal

Published: October 15, 2025

Electrochemotherapy in the Management of Vascular Malformations: An Updated Systematic Review.

Electrochemotherapy in the Management of Vascular Malformations: An Updated Systematic Review.

Journal: Clinics and practice

Published: October 14, 2025

Beyond Programmed Death-Ligand 1: Gut Microbiome Composition as a Biomarker For First-Line Chemoimmunotherapy in Advanced NSCLC.

Beyond Programmed Death-Ligand 1: Gut Microbiome Composition as a Biomarker For First-Line Chemoimmunotherapy in Advanced NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 20, 2025

Impact of metabolic syndrome on the prognosis of endometrial cancer: A systematic review of evidence.

Impact of metabolic syndrome on the prognosis of endometrial cancer: A systematic review of evidence.

Journal: Clinical nutrition ESPEN

Published: April 15, 2025

Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target.

Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target.

Journal: Cancer treatment reviews

Published: December 23, 2024

Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experience.

Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experience.

Journal: International journal of cancer

Published: August 18, 2024

Microvessel density in patients with gastrointestinal stromal tumors: A systematic review and meta-analysis.

Microvessel density in patients with gastrointestinal stromal tumors: A systematic review and meta-analysis.

Journal: World journal of methodology

Published: January 14, 2023

Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis.

Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis.

Journal: World journal of methodology

Published: October 28, 2021

Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis.

Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis.

Journal: Journal of skin cancer

Published: August 30, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026